LEVOSIMENDAN Ideogen 12,5 mg/5 ml conc perf 12.5 m

7680699640010 CH-69964 C01CX08 02.05.2.

No images available

Details

Product number
6996401
CPT
-
Packaging group
1 x 5 ml
Unit
Durchstechflasche(n)
Composition
levosimendanum 12.5 mg, povidonum K 12, acidum citricum, ethanolum anhydricum 3847.5 mg, ad solutionem pro 5 ml, corresp. ethanolum 98 % V/V.

Articles (1)

Levosimendan Ideogen 12,5 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1 x 5 ml
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
levosimendanum
12.5 MG Substance Wirkstoff (Principe actif)
povidonum K 12
- Substance HNIDK
acidum citricum
- Substance HNIDK
ethanolum anhydricum
3847.5 MG Substance HBESI

Authorization holder

IDEOGEN AG

8807 Freienbach

Authorization information

Swissmedic authorization number
69964
Drug name
Levosimendan Ideogen, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
C01CX08
Authorization status
Z
Dispensation category
A
First authorization
13/08/2026
Authorization expiration date
12/08/2031
IT number
02.05.2.
Domain
Human medicine
Field of application
Akut dekompensierte chronische Herzinsuffizienz

Packaging details

Description (FR)
LEVOSIMENDAN Ideogen 12,5 mg/5 ml conc perf 12.5 m
Description (DE)
LEVOSIMENDAN Ideogen 12,5 mg/5 ml Konz Inf 12.5 mg
Market launch
02/09/2027
Narcotic (BTM)
No

Other packaging sizes

LEVOSIMENDAN Ideogen 12,5 mg/5 ml conc perf 12.5 m
4 x 5 ml DUR
View
Buy us a coffee Explore the data